In Morocco, cervical cancer and precancerous lesions are still a public health problem and many efforts are made to improve women's awareness on Human papillomavirus (HPV) infection and methods preventing its dissemination. This study was planned to evaluate HPV prevalence and to assess the predominant HPV genotypes circulating in Morocco. A total of 360 women, attending caravans of sensitization and screening for cervical lesions were recruited from 9 different regions of Morocco. Socio-demographic, familial and medical data of participating women were recorded. HPV testing and genotyping were performed by Polymerase Chain Reaction and DNA direct sequencing. The overall HPV prevalence was 30.28% of the recruited women. Of the positive samples, 61.46%
Introduction
Worldwide, cervical cancer (CC) is the fourth most common type of cancer among women, with 569,847 new cases diagnosed in year 2018 alone, and approximately 87.3% of these occur in low-and middleincome countries (LMIC), according to the incidence data from GLOBOCAN database (https://gco.iarc.fr/today). Currently, there is scientific evidence that Human papillomavirus (HPV) play a central role in CC development and HPV DNA is found in 95 to 100% of cases [1] . HPV infection of metaplastic epithelium at the cervical transformation zone, is considered as the first step of CC development that occurs after viral persistence and progression of persistently infected epithelium to cervical pre-cancer and cancer [2] . To date, more than 200 HPV genotypes have been identified [3] , but the attention is still focused on 14 HPV types which are the most involved in precancerous and cancerous lesions of the cervix, and frequently found in mucosal epithelium of the genital tract and other mucosal areas of the human body [4] .
HPVs are classified according to their involvement in the genesis of benign or malignant lesions. Accordingly, low-risk oncogenic HPVs (LR-HPV) are associated with anogenital benign warts, predominantly caused by HPV 6 and 11; and high-risk oncogenic HPVs (HR-HPV) are clearly associated with malignant cervical lesions including types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 , and 68 [2, [5] [6] [7] . Scientific data clearly showed that HPV 16 and 18 are the most frequently found genotypes in association with CC worldwide and are consequently considered as the most oncogenic types. However, prevalence of other genotypes is related to geographic or ethnic distribution [8] .
In Morocco, CC is considered as a public health problem and data from two distinct cancer registries
show that this malignancy ranks as the second most 
Materials and methods

Study design
The study was conducted in the frame of a caravan of 
HPV detection
HPV detection was performed by nested PCR using consecutively MY09/11 and GP5+/6+ primers [17, 18] . 
Results
In this study, 360 women from different regions of In this study, HPV detection was performed by Nested PCR widely reported as the most sensitive method for detection of HPV infection in clinical samples [20] . The overall HPV prevalence was 30.28%. Notably, this prevalence was significantly higher compared to the prevalence reported by Alhamany et al. [14] in Rabat (15.7%) and lower than those reported in women from Fez and its neighborhood by Bennani et al. [15] and Souho et al. [21] which were 42.5% and 43.1%, respectively. Globally, HPV prevalence in Africa in women without CC is estimated to be 22.1%, and is much lower in Europe (8.1%) and Asia (8.0%) [22] .
Results obtained in this study are in agreement with those reported in many African countries such as Tunisia (34%), Cameroon (38.5%), Gabon (46%) and
Congo (60.4) [22] [23] [24] [25] .
We detected 11 different HPV genotypes; 7 HR-HPV high HPV prevalence appears to differ across geographical regions. Some studies have reported an increase of HPV infection in women older than 45 years [17, 22] . However, a large meta-analysis conducted by Smith and coll. showed inconsistent trends in HPV prevalence by age in older women, with a decrease or plateau of HPV prevalence in older ages in most studies, whereas others showed an increase of HPV prevalence in older ages [29] . Moreover, Masia et al. found that HPV and HR HPV prevalence significantly declined in women older than 46 years in women from Sardinia, Italy [30] .
In Morocco, data are also controversial. In Fez and its neighborhood, the high HPV prevalence was observed in older women [21] . However, no significant difference was reported between younger and older women from Rabat [14] . These contradictory results may reflect differences in sexual behavior across cities and/or countries.
It is also noteworthy that women living in urban areas were more likely to be at risk of HPV infection than those living in rural area. This difference in HPV distribution could be related to sexual habits and the level of conservative behavior between rural and urban areas; usually rural communities are more conservative compared to urban communities. Similar results were already reported in Eastern Brazilian Amazon [31] and Shenzhen region of China [32] , where HPV prevalence was higher in urban than in rural areas.
The present study is very informative and its effectiveness is mainly related to the multi-sites sample collection. In fact, this is the first study evaluating HPV prevalence and determining HPV genotypes in women all coming, without presumption of cervical lesions, recruited in 9 distinct regions. Moreover, recruitment was done in both urban and rural areas and included both young and elder' women. However, the main limitation of the study is the small sample size, and limited number of regions due to campaigns organization costs.
Conclusion
In conclusion, this study clearly showed that HPV infection is high in Moroccan women. Moreover, these findings show the predominance of HPV 16 and 18 in cervical swabs, and represent together more than 30% of total HPV positive cases, suggesting that the two available vaccines in Morocco, Gardasil and Cervarix, could be of a great advantage in protecting women against HPV infection and limit HPV dissemination in the whole country. Moreover, introduction of Gardasil 9
in Morocco is highly encouraged as this will enhance HPV protection of Moroccan women.
